EUVIMED · CrossrefJournal
Journal of Inherited Metabolic Disease
ISSN 0141-8955 · Wiley
Latest articles
Bringing Untargeted Metabolomics to the Clinic: Real‐World Data and Implementation for Screening of Inherited Metabolic Diseases
Migalastat Versus Enzyme Replacement Therapy in Treatment‐Naïve F abry Disease: Real‐World Evidence From the followME F abry Pathfinders Registry
Nucleic Acid Therapeutics in Rare Disease: From Precision Medicine to Programmable Platforms
Thymidine Kinase 2 Deficiency in the Era of Approved Therapy: From Diagnosis to Evidence Across the Disease Spectrum
Proteo‐Metabolomic Profiling of PMM2 ‐ CDG Reveals Dysregulation of Retinoic Acid Synthesis, Myo ‐Inositol, and the Hexosamine Pathway
Occurrence of Infusion Associated Reactions and Antidrug Antibodies in Enzyme Replacement Therapy for Fabry Disease and the Effect of Preventive Measures
Phase 3 Randomized Trial Results of DTX401 AAV Gene Therapy for the Treatment of GSDIa
First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders
Methionine Synthase Interacts With the Methionine Adenosyl‐Transferase MATα2 and the DNA Methyltransferase DNMT3b in the Nucleus
A Rapamycin Pharmacogenomic Approach for the Childhood Dementia N iemann‐ P ick C
Biallelic Loss‐Of‐Function Variant in ATP5ME Is Associated With Severe and Early Onset Oxidative Phosphorylation Deficiency
Aminoacyl‐ tRNA Synthetases: Variant Classification, Functional Assays, and Emerging Therapeutic Strategies
2025 Consensus Clinical Management Guidelines for Niemann‐Pick Disease Type C
Liver Gene Therapy in Fabry Disease Mice With Low Doses of rAAV2 /8 Expressing a Codon‐Optimized h GLA cDNA Results in Long‐Term Disease Correction
Adults With Acid Sphingomyelinase Deficiency Have Sustained Improvements in Clinical Outcomes With up to 5 Years of Olipudase Alfa Enzyme Replacement Therapy: ASCEND Trial Final Results
Multimodal Noninvasive Biomarker Characterization of Structural and Functional Alterations in ADSS1 ‐Deficient Myopathy
Shifting Towards Empagliflozin First‐Line Therapy in Glycogen Storage Disease Type Ib: A Nationwide Real‐World Study
Natural History of Morquio A Syndrome
RNA ‐Based Therapies for Inherited Metabolic Disorders
Pharmacodynamics, Efficacy, and Safety of Intraputaminal Eladocagene Exuparvovec Administered to Pediatric Patients With Aromatic L‐Amino Acid Decarboxylase Deficiency Using an MR ‐Compatible Cannula: 48 Weeks of Follow‐Up
A Meta‐Analysis to Unveil the Diagnostic Gaps in Anderson–Fabry Disease in Women
Clinical Characteristics of Arginase 1 Deficiency: Natural History Insights From International Clinical Trials
The Grey Zone Project: Risk‐Based Classification of ABCD1 Variants in X‐Linked Adrenoleukodystrophy
Untargeted Metabolomics for Diagnosis, Monitoring, and Understanding the Pathophysiology of Inherited Metabolic Disorders
Exploring Outcome Measures for Mitochondrial Myopathies; Insights From a Longitudinal Study on TK2 Deficiency
Revisiting the Genetics of Hypophosphatasia
The Evolving Trend of Liver Transplantation in Metabolic Diseases: From Origins to Current Perspectives
Exploring a Circulating miRNA Signature for PMM2 ‐ CDG : Initial Insights Toward Diagnosis, Stratification, and Monitoring
Personalized Genome‐Scale Modeling Reveals Metabolic Perturbations in Fibroblasts of Methylmalonic Aciduria Patients
Delivering the Message: Translating mRNA Therapy for Liver Inherited Metabolic Diseases
Volumes
2026 · 1062025 · 1872024 · 1132023 · 1132022 · 1212021 · 1422020 · 1442019 · 1272018 · 1552017 · 1002016 · 1012015 · 1312014 · 1182013 · 1272012 · 1272011 · 1472010 · 2012009 · 1572008 · 1482007 · 1792006 · 1532005 · 1582004 · 1312003 · 1192002 · 902001 · 1422000 · 1401999 · 1691998 · 1851997 · 1591996 · 1581995 · 1731994 · 1651993 · 1931992 · 1611991 · 1691990 · 1471989 · 1501988 · 1291987 · 136
EUVIMED